{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:17:55Z","timestamp":1754151475655,"version":"3.41.2"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,7,15]]},"DOI":"10.2169\/internalmedicine.4655-24","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T17:14:03Z","timestamp":1735146843000},"page":"2165-2169","source":"Crossref","is-referenced-by-count":0,"title":["Ulcerative Colitis with Acute Pericarditis after Dose Escalation of Mesalazine"],"prefix":"10.2169","volume":"64","author":[{"given":"Jun","family":"Wada","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Onizawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Gunji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Watahiki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Mochimaru","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Welch TD, Ling LH, Espinosa RE, et al. Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria. Circ Cardiovasc Imaging 7: 526-534, 2014.","DOI":"10.1161\/CIRCIMAGING.113.001613"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Casella G, Villanacci V, Di Bella C, Antonelli E, Baldini V, Bassotti G. Pulmonary diseases associated with inflammatory bowel diseases. J Crohns Colitis 4: 384-389, 2010.","DOI":"10.1016\/j.crohns.2010.02.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129: 827-836, 2005.","DOI":"10.1053\/j.gastro.2005.06.021"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 56: 489-526, 2021.","DOI":"10.1007\/s00535-021-01784-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Radhakrishnan ST, Mohanaruban A, Hoque S. Mesalazine-induced myocarditis: a case report. J Med Case Rep 12: 44, 2018.","DOI":"10.1186\/s13256-017-1557-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen J, Duan T, Fang W, Liu S, Wang C. Analysis of clinical characteristics of mesalazine-induced cardiotoxicity. Front Pharmacol 13: 970597, 2022.","DOI":"10.3389\/fphar.2022.970597"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Kristensen KS, H\u00f8egholm A, Bohr L, Friis S. Fatal myocarditis associated with mesalazine. Lancet 335: 605, 1990.","DOI":"10.1016\/0140-6736(90)90387-K"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Park EH, Kim BJ, Huh JK, et al. Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis. J Cardiovasc Ultrasound 20: 154-156, 2012.","DOI":"10.4250\/jcu.2012.20.3.154"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Saito D, Hayashida M, Sato T, et al. Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy. Intest Res 16: 273-281, 2018.","DOI":"10.5217\/ir.2018.16.2.273"},{"key":"10","unstructured":"10. Vayre F, Vayre-Oundjian LO, Monsuez JJ. Pericarditis associated with longstanding mesalazine administration in a patient. Int J Cardiol 68: 243-245, 1999."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Dias T, Santos A, Santos R. Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis. BMJ Case Rep 12: e228037, 2019.","DOI":"10.1136\/bcr-2018-228037"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kiyomatsu H, Kawai K, Tanaka T. Mesalazine-induced pleuropericarditis in a patient with Crohn&apos;s disease. Intern Med 54: 1605-1608, 2015.","DOI":"10.2169\/internalmedicine.54.4316"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Oxentenko AS, Loftus EV, Oh JK. Constrictive pericarditis in chronic ulcerative colitis. J Clin Gastroenterol 34: 247-251, 2002.","DOI":"10.1097\/00004836-200203000-00011"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gujral N, Friedenberg F, Friedenberg J. Pleuropericarditis related to the use of mesalamine. Dig Dis Sci 41: 624-626, 1996.","DOI":"10.1007\/BF02282352"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Karki P, Kunwar A, Sharma N. Recurrent pericarditis: a rare adverse effect of mesalamine. Cureus 15: e33661, 2023.","DOI":"10.7759\/cureus.33661"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Caio G, Lungaro L, Caputo F. Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature. BMJ Open Gastroenterol 8: e000587, 2021.","DOI":"10.1136\/bmjgast-2020-000587"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Waite RA, Malinowski JM. Possible mesalamine-induced pericarditis: case report and literature review. Pharmacotherapy 22: 391-394, 2002.","DOI":"10.1592\/phco.22.5.391.33188"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shergill S. Mesalazine-induced myopericarditis: a case report. Eur Heart J Case Rep 5: ytaa508, 2020.","DOI":"10.1093\/ehjcr\/ytaa508"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mohamed E, Abubaker A, Jaafar AK. Mesalamine-induced myopericarditis: a case report and literature review. Cardiol Res 10: 59-62, 2019.","DOI":"10.14740\/cr820"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bernardo S, Raimundo S, Correia A. Mesalamine-induced myopericarditis - a case report. Rev Esp Enferm Dig 108: 753-756, 2016.","DOI":"10.17235\/reed.2016.4016\/2015"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ishikawa N, Imamura T, Nakajima K. Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis. Intern Med 40: 901-904, 2001.","DOI":"10.2169\/internalmedicine.40.901"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Okoro KU, Roby MD, Bankole AA. Myocarditis secondary to mesalamine-induced cardiotoxicity in a patient with ulcerative colitis. Case Rep Med 2018: 9813893, 2018.","DOI":"10.1155\/2018\/9813893"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/14\/64_4655-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T03:50:22Z","timestamp":1752897022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/14\/64_4655-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":22,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4655-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"article-number":"4655-24"}}